Prime Minister Imran Khan had already taken notice of the medicine prices.
“There were so many issues in the Drug Regulatory Authority of Pakistan (Drap) and even the record had disappeared. We have been establishing a website so that the record would not be lost in future. Moreover, it has been decided to hold a special audit of Drap.”
Strict action was being taken against companies for not reducing prices.
“Pakistan is exporting medicines worth $200 million only while India’s drug export is worth $2 billion. The prime minister has also condemned the increase in prices and hopefully it would be reduced soon.
authority has recommended registering of cases on overpriced medicines under the Drug Act, besides imposing heavy fines with recovery of overpriced amount. Cases would be registered against the companies on overpricing for recovery of the overpriced amount. Action has also been taken on receiving various complaints that pharmaceutical companies have increased prices of drugs over and above the maximum retail price (MRPs) approved by the federal government.